Dose-dependent vitamin D3, 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3-induced hypercalcemia and hyperphosphatemia, and the correlative changes in the activity of ultimobranchial and parathyroid glands of the toad, Bufo andersoni Boulenger

Biol Struct Morphog. 1992;4(4):174-81.

Abstract

Vitamin D3, 25(OH) vitamin D3 and 1,25 (OH)2D3 were administered daily to unfed male Bufo andersoni for 15 days which resulted in a significant hypercalcemia and hyperphosphatemia in a dose-dependent fashion. 1,25(OH)2D3 is more potent than the other metabolites. The treatment activated ultimobranchial gland but induced degenerative changes in parathyroid of the toads.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bufonidae
  • Calcifediol / pharmacology*
  • Calcitriol / pharmacology*
  • Calcium / blood
  • Cholecalciferol / pharmacology*
  • Dose-Response Relationship, Drug
  • Hypercalcemia / blood
  • Hypercalcemia / chemically induced*
  • Male
  • Parathyroid Glands / drug effects
  • Parathyroid Glands / metabolism*
  • Phosphates / blood*
  • Ultimobranchial Body / drug effects
  • Ultimobranchial Body / metabolism*

Substances

  • Phosphates
  • Cholecalciferol
  • Calcitriol
  • Calcifediol
  • Calcium